These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5396489)

  • 21. Laboratory studies with a new cephalosporanic acid derivative.
    Chisholm DR; Leitner F; Misiek M; Wright GE; Price KE
    Antimicrob Agents Chemother (Bethesda); 1969; 9():244-6. PubMed ID: 5396494
    [No Abstract]   [Full Text] [Related]  

  • 22. How useful are antibiotic sensitivity tests?
    Smith JM
    N Z Med J; 1990 Apr; 103(887):149-50. PubMed ID: 2342669
    [No Abstract]   [Full Text] [Related]  

  • 23. Pyrrole analogues of chloramphenicol. III. Synthesis and antibacterial activity of DL-threo-1-(1-methylsulfonylpyrrole-3-yl)-2-dichloroacetamidopropane-1,3-diol.
    Krajewska D; Dabrowska M; Jakoniuk P; Rózański A
    Acta Pol Pharm; 2002; 59(2):127-32. PubMed ID: 12365604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological activities of some new fluorinated coumarins and 1-aza coumarins.
    Kalkhambkar RG; Kulkarni GM; Kamanavalli CM; Premkumar N; Asdaq SM; Sun CM
    Eur J Med Chem; 2008 Oct; 43(10):2178-88. PubMed ID: 17959273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Superhelical Escherichia coli DNA: relaxation by coumermycin.
    Drlica K; Snyder M
    J Mol Biol; 1978 Apr; 120(2):145-54. PubMed ID: 347091
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro anti-Gram-positive and antistaphylococcal biofilm activity of newly halogenated pyrroles related to pyrrolomycins.
    Schillaci D; Petruso S; Cascioferro S; Raimondi MV; Haagensen JA; Molin S
    Int J Antimicrob Agents; 2008 Apr; 31(4):380-2. PubMed ID: 18082373
    [No Abstract]   [Full Text] [Related]  

  • 27. Pyrrole analogues of chloramphenicol. I. Synthesis and antibacterial activity of DL-threo-1-(1-methyl-4-nitropyrrole-2-yl)-2-dichloroacetamidopropane-1,3-diol.
    Krajewska D; Dabrowska M; Jakoniuk P; Rózański A
    Acta Pol Pharm; 2000; 57(3):213-21. PubMed ID: 11143711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Copper complexes of imidazole-2-, pyrrole-2- and indol-3-carbaldehyde thiosemicarbazones: inhibitory activity against fungi and bacteria.
    Rodríguez-Argüelles MC; López-Silva EC; Sanmartín J; Pelagatti P; Zani F
    J Inorg Biochem; 2005 Nov; 99(11):2231-9. PubMed ID: 16188319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antimicrobial susceptibility testing of bacteria isolated from animals: considerations concerning the predefinition of breakpoints from the clinical pharmacological viewpoint].
    Kietzmann M; Böttner A; Hafez HM; Kehrenberg C; Klarmann D; Krabisch P; Kühn T; Luhofer G; Richter A; Schwarz S; Traeder W; Waldmann KH; Wallmann J; Werckenthin C; ;
    Berl Munch Tierarztl Wochenschr; 2004; 117(3-4):81-7. PubMed ID: 15046455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibacterial and anticoagulant activities of coumarins isolated from the flowers of Magydaris tomentosa.
    Rosselli S; Maggio A; Bellone G; Formisano C; Basile A; Cicala C; Alfieri A; Mascolo N; Bruno M
    Planta Med; 2007 Feb; 73(2):116-20. PubMed ID: 17128388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New pyrrolo-pyrimidine derivatives with antifungal or antibacterial properties in vitro].
    Mangalagiu G; Ungureanu M; Grosu G; Mangalagiu I; Petrovanu M
    Ann Pharm Fr; 2001 Apr; 59(2):139-40. PubMed ID: 11320339
    [No Abstract]   [Full Text] [Related]  

  • 32. Emergence and maintenance of resistance to fluoroquinolones and coumarins in Staphylococcus aureus: predictions from in vitro studies.
    Vickers AA; O'Neill AJ; Chopra I
    J Antimicrob Chemother; 2007 Aug; 60(2):269-73. PubMed ID: 17556355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyrrolnitrin analogues. VIII - Synthesis and antibacterial activity of new 1,4- and 1,5-diarylpyrroles.
    Filacchioni G; Porretta GC; Scalzo M; Giardina MC; Giardi T
    Farmaco Sci; 1983 Sep; 38(9):630-9. PubMed ID: 6641928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Criteria of evaluation of efficacy of antibiotics. 2. Relationship between sensitivity tests and clinical effects].
    Sasaki J; Goto J; Ichikawa T; Matsuzaki T; Iwamoto M
    Shikwa Gakuho; 1970 Oct; 70(10):1299-301. PubMed ID: 5274283
    [No Abstract]   [Full Text] [Related]  

  • 35. Biosynthesis of coumermycin A1: incorporation of L-proline into the pyrrole groups.
    Scannell J; Kong YL
    Antimicrob Agents Chemother (Bethesda); 1969; 9():139-43. PubMed ID: 5396481
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro activity of coumermycin A1 against Mycobacterium tuberculosis var. hominis.
    Duma RJ; Warner JF
    Appl Microbiol; 1969 Sep; 18(3):404-5. PubMed ID: 4984765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of some new substituted benzofuran derivatives as potentially active antimicrobial agents.
    Abdel-Rahman AH; Khalil AM; Hanna MA
    Boll Chim Farm; 1997 Mar; 136(3):262-5. PubMed ID: 9164167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1,3-Dimethylpyrimidoheterocycles as antibacterial agents.
    Zoorob HH; Abou Elzahab M; Abdel-Mogib M; Ismail MA; Abdel-Hamid M
    Arzneimittelforschung; 1997 Aug; 47(8):958-62. PubMed ID: 9296283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Apropos of antibiotics].
    Boismare F; Streichenberger G
    Cah Coll Med Hop Paris; 1969 Aug; 10(10):861-9. PubMed ID: 5400577
    [No Abstract]   [Full Text] [Related]  

  • 40. New 4-arylhydrazono-5(4H)-isoxazolone derivatives as possible antibacterial and anticonvulsant agents.
    Ergenç N; Capan G; Otük G
    Pharmazie; 1993 Oct; 48(10):780-2. PubMed ID: 8265714
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.